Speaker illustration

Doctor Yoriyasu Suzuki

Nagoya Heart Center, Nagoya (Japan)

Efficacy of tolvaptan in treating patients with heart failure with the preserved ejection fraction

Event: Acute Cardiovascular Care 2019

Topic: Pharmacotherapy

Session: Acute Heart Failure: Pharmacotherapy


Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Acute Heart Failure– Treatment


Prevalence and clinical impact of tissue protrusion after stent implantation for acute coronary syndrome

Event: ESC CONGRESS 2017

Topic: PCI: primary PCI / patient subsets

Session: Primary and acute PCI


ESC 365 is supported by

logo Novo Nordisk